US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 4.120
  • +1.000+32.05%
Close Oct 11 16:00 ET
  • 3.610
  • -0.510-12.38%
Post 20:01 ET
5.49MMarket Cap-716P/E (TTM)

Dogwood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.58%1.07M
-15.62%1.31M
-55.77%5.45M
-45.54%1.14M
-50.84%1.27M
-59.77%1.48M
-60.69%1.56M
-21.26%12.32M
-50.10%2.09M
-36.95%2.59M
Selling and administrative expenses
-20.19%733.74K
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
-15.68%969.95K
-General and administrative expense
-20.19%733.74K
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
-15.68%969.95K
Research and development costs
-39.75%336.08K
-30.94%343.72K
-78.59%1.73M
-76.54%298.32K
-76.94%374.2K
-76.82%557.84K
-82.03%497.71K
-25.25%8.07M
-56.42%1.27M
-45.21%1.62M
Operating profit
27.58%-1.07M
15.62%-1.31M
55.77%-5.45M
45.54%-1.14M
50.84%-1.27M
59.77%-1.48M
60.69%-1.56M
21.26%-12.32M
50.10%-2.09M
36.95%-2.59M
Net non-operating interest income expense
-44.95%19.99K
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
40.42K
1,089.62%67.48K
3,464.33%45.16K
1,000.40%16.61K
Non-operating interest income
-44.95%19.99K
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
--40.42K
--67.48K
--45.16K
1,000.40%16.61K
Other net income (expense)
Income before tax
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
Net income continuous Operations
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
Minority interest income
Net income attributable to the parent company
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
37.33%-2.58M
Basic earnings per share
37.50%-1.25
12.50%-1.75
74.77%-7
45.45%-1.5
78.57%-1.5
81.82%-2
83.33%-2
42.19%-27.75
79.63%-2.75
42.86%-7
Diluted earnings per share
37.50%-1.25
12.50%-1.75
74.77%-7
45.45%-1.5
78.57%-1.5
81.82%-2
83.33%-2
42.19%-27.75
79.63%-2.75
42.86%-7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.58%1.07M-15.62%1.31M-55.77%5.45M-45.54%1.14M-50.84%1.27M-59.77%1.48M-60.69%1.56M-21.26%12.32M-50.10%2.09M-36.95%2.59M
Selling and administrative expenses -20.19%733.74K-8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K-15.68%969.95K
-General and administrative expense -20.19%733.74K-8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K-15.68%969.95K
Research and development costs -39.75%336.08K-30.94%343.72K-78.59%1.73M-76.54%298.32K-76.94%374.2K-76.82%557.84K-82.03%497.71K-25.25%8.07M-56.42%1.27M-45.21%1.62M
Operating profit 27.58%-1.07M15.62%-1.31M55.77%-5.45M45.54%-1.14M50.84%-1.27M59.77%-1.48M60.69%-1.56M21.26%-12.32M50.10%-2.09M36.95%-2.59M
Net non-operating interest income expense -44.95%19.99K-43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K40.42K1,089.62%67.48K3,464.33%45.16K1,000.40%16.61K
Non-operating interest income -44.95%19.99K-43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K--40.42K--67.48K--45.16K1,000.40%16.61K
Other net income (expense)
Income before tax 27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M
Income tax 0000000000
Net income 27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M
Net income continuous Operations 27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M
Minority interest income
Net income attributable to the parent company 27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M37.33%-2.58M
Basic earnings per share 37.50%-1.2512.50%-1.7574.77%-745.45%-1.578.57%-1.581.82%-283.33%-242.19%-27.7579.63%-2.7542.86%-7
Diluted earnings per share 37.50%-1.2512.50%-1.7574.77%-745.45%-1.578.57%-1.581.82%-283.33%-242.19%-27.7579.63%-2.7542.86%-7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.67%